Literature DB >> 3591561

Human tumor antigens.

R A Reisfeld, D A Cheresh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591561     DOI: 10.1016/s0065-2776(08)60242-4

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  17 in total

1.  Mouse monoclonal antibodies against human sperm: evidence for immunodominant glycosylated antigenic sites.

Authors:  M Kurpisz; G F Clark; M Mahony; T L Anderson; N J Alexander
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.

Authors:  U Holzer; W Bethge; F Krull; J Ihle; R Handgretinger; R A Reisfeld; M Dohlsten; T Kalland; D Niethammer; G E Dannecker
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968

Review 3.  Idiotypic antibody immunotherapy of cancer.

Authors:  M B Chatterjee; K A Foon; H Köhler
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

4.  Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.

Authors:  P Chattopadhyay; J Starkey; W J Morrow; S Raychaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 5.  Composition and production of pancreatic tumor related antigens.

Authors:  H E Appert
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

6.  Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.

Authors:  Yanbin Pan; Peter Chefalo; Nancy Nagy; Clifford Harding; Zhongwu Guo
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

7.  Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

Authors:  A Mittelman; Z J Chen; T Kageshita; H Yang; M Yamada; P Baskind; N Goldberg; C Puccio; T Ahmed; Z Arlin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

8.  Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement.

Authors:  B Wang; Y B Chen; O Ayalon; J Bender; A Garen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.

Authors:  Peter Chefalo; Yanbin Pan; Nancy Nagy; Zhongwu Guo; Clifford V Harding
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

10.  Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.

Authors:  Qianli Wang; Junping Zhang; Zhongwu Guo
Journal:  Bioorg Med Chem       Date:  2007-09-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.